Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal involuntary movements, limiting its use in advanced stages of the disease. An increasing body of evidence points to the serotonin system as a key player in the appearance of L-DOPA-induced dyskinesia...
Saved in:
Main Authors: | Eunju Shin, Elisabetta Tronci, Manolo Carta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2012/370190 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
by: Veronica Ghiglieri, et al.
Published: (2012-01-01) -
Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
by: Huan Du, et al.
Published: (2015-01-01) -
Dyskinesia in Parkinson's Disease Therapy
by: Anna Rosa Carta, et al.
Published: (2012-01-01) -
Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01) -
Tyrosine Hydroxylase Expression in Differentiating Neurons of the
Rat Arcuate Nucleus: Stimulatory Influence of Serotonin Afferents
by: Viktoria I. Melnikova, et al.
Published: (2001-01-01)